Geoffrey M. Parker - Net Worth and Insider Trading

Geoffrey M. Parker Net Worth

The estimated net worth of Geoffrey M. Parker is at least $13 Million dollars as of 2024-03-28. Geoffrey M. Parker is the Director of ChemoCentryx Inc and owns about 129,603 shares of ChemoCentryx Inc (CCXI) stock worth over $7 Million. Geoffrey M. Parker is the CHIEF FINANCIAL OFFICER of Allogene Therapeutics Inc and owns about 819,590 shares of Allogene Therapeutics Inc (ALLO) stock worth over $4 Million. Geoffrey M. Parker is also the Director of Perrigo Co PLC and owns about 47,084 shares of Perrigo Co PLC (PRGO) stock worth over $2 Million. Besides these, Geoffrey M. Parker also holds Anacor Pharmaceuticals Inc (ANAC) , Better Therapeutics Inc (BTTX) , Sunesis Pharmaceuticals Inc (SNSS) , Tricida Inc (TCDAQ) . Details can be seen in Geoffrey M. Parker's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Geoffrey M. Parker has not made any transactions after 2024-01-30 and currently still holds the listed stock(s).

Transaction Summary of Geoffrey M. Parker

To

Geoffrey M. Parker Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Geoffrey M. Parker owns 9 companies in total, including Tricida Inc () , ChemoCentryx Inc () , and Perrigo Co PLC () among others .

Click here to see the complete history of Geoffrey M. Parker’s form 4 insider trades.

Insider Ownership Summary of Geoffrey M. Parker

Ticker Comapny Transaction Date Type of Owner
Tricida Inc 2020-12-10 Chief Fin. Officer and Sr. VP
ChemoCentryx Inc 2021-03-05 director
Perrigo Co PLC 2023-06-13 director
Sunesis Pharmaceuticals Inc 2017-05-31 director
Anacor Pharmaceuticals Inc 2015-03-23 Executive Vice President & CFO
Viracta Therapeutics Inc 2016-03-23 director
Better Therapeutics Inc 2023-07-27 director
Mountain Crest Acquisition Corp II 2021-10-28 director
Allogene Therapeutics Inc 2024-01-30 CHIEF FINANCIAL OFFICER

Geoffrey M. Parker Latest Holdings Summary

Geoffrey M. Parker currently owns a total of 7 stocks. Among these stocks, Geoffrey M. Parker owns 129,603 shares of ChemoCentryx Inc (CCXI) as of March 5, 2021, with a value of $7 Million and a weighting of 52.06%. Geoffrey M. Parker owns 819,590 shares of Allogene Therapeutics Inc (ALLO) as of January 30, 2024, with a value of $4 Million and a weighting of 28.09%. Geoffrey M. Parker also owns 47,084 shares of Perrigo Co PLC (PRGO) as of June 13, 2023, with a value of $2 Million and a weighting of 11.71%. The other 4 stocks Anacor Pharmaceuticals Inc (ANAC) , Better Therapeutics Inc (BTTX) , Sunesis Pharmaceuticals Inc (SNSS) , Tricida Inc (TCDAQ) have a combined weighting of 8.14% among all his current holdings.

Latest Holdings of Geoffrey M. Parker

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CCXI ChemoCentryx Inc 2021-03-05 129,603 51.99 6,738,060
ALLO Allogene Therapeutics Inc 2024-01-30 819,590 4.44 3,634,882
PRGO Perrigo Co PLC 2023-06-13 47,084 32.18 1,515,163
ANAC Anacor Pharmaceuticals Inc 2015-03-23 104,840 9.82 1,029,529
BTTX Better Therapeutics Inc 2023-07-27 1,081,388 0.01 14,491
SNSS Sunesis Pharmaceuticals Inc 2016-12-09 1,878 5.32 9,991
TCDAQ Tricida Inc 2020-12-10 250,837 0.00 3

Holding Weightings of Geoffrey M. Parker


Geoffrey M. Parker Form 4 Trading Tracker

According to the SEC Form 4 filings, Geoffrey M. Parker has made a total of 3 transactions in ChemoCentryx Inc (CCXI) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in ChemoCentryx Inc is the sale of 31,910 shares on March 5, 2021, which brought Geoffrey M. Parker around $2 Million.

According to the SEC Form 4 filings, Geoffrey M. Parker has made a total of 1 transactions in Allogene Therapeutics Inc (ALLO) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Allogene Therapeutics Inc is the acquisition of 190 shares on January 30, 2024, which cost Geoffrey M. Parker around $684.

According to the SEC Form 4 filings, Geoffrey M. Parker has made a total of 4 transactions in Perrigo Co PLC (PRGO) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in Perrigo Co PLC is the acquisition of 10,000 shares on June 13, 2023, which cost Geoffrey M. Parker around $330,600.

More details on Geoffrey M. Parker's insider transactions can be found in the Insider Trading History of Geoffrey M. Parker table.

Insider Trading History of Geoffrey M. Parker

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Geoffrey M. Parker Trading Performance

GuruFocus tracks the stock performance after each of Geoffrey M. Parker's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Geoffrey M. Parker is 6.64%. GuruFocus also compares Geoffrey M. Parker's trading performance to market benchmark return within the same time period. The performance of stocks bought by Geoffrey M. Parker within 3 months outperforms 17 times out of 39 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Geoffrey M. Parker's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Geoffrey M. Parker

Average Relative Return

39.02%

Average relative return per transaction

Outperforming Transactions

53%

19 out of 36 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Relative Return(%) 2.95 6.64 12.64 39.02 31.52 14.64
Relative Return to S&P 500(%) 2.65 4.37 8.54 25.99 19.75 2.38

Geoffrey M. Parker Ownership Network

Ownership Network List of Geoffrey M. Parker

No Data

Ownership Network Relation of Geoffrey M. Parker


Geoffrey M. Parker Owned Company Details

What does Tricida Inc do?

Who are the key executives at Tricida Inc?

Geoffrey M. Parker is the Chief Fin. Officer and Sr. VP of Tricida Inc. Other key executives at Tricida Inc include director & 10 percent owner Orbimed Advisors Llc , director & 10 percent owner David P Bonita , and 10 percent owner Venrock Healthcare Capital Partners Ii, L.p. .

Tricida Inc () Insider Trades Summary

Over the past 18 months, Geoffrey M. Parker made no insider transaction in Tricida Inc (). Other recent insider transactions involving Tricida Inc () include a net sale of 5,130,471 shares made by Venrock Healthcare Capital Partners Ii, L.p. , a net sale of 159,463 shares made by Robert J Alpern , and a net sale of 10,280,947 shares made by Orbimed Advisors Llc .

In summary, during the past 3 months, insiders sold 0 shares of Tricida Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 27,532,897 shares of Tricida Inc () were sold and 1,321,069 shares were bought by its insiders, resulting in a net sale of 26,211,828 shares.

Tricida Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Tricida Inc Insider Transactions

No Available Data

Geoffrey M. Parker Mailing Address

Above is the net worth, insider trading, and ownership report for Geoffrey M. Parker. You might contact Geoffrey M. Parker via mailing address: 15 Riordan Place, Menlo Park Ca 94025.

Discussions on Geoffrey M. Parker

No discussions yet.